业务体系

BUSINESS

Business Model

奥祺主营业务由三块构成：成熟制剂 License in、自研产品 License out，以及面向 CGT 早研项目的种子孵化服务。

Aoqi's business comprises three pillars: License-in of mature formulations, License-out of self-developed products, and incubation services for early-stage CGT projects.

01 · LICENSE IN

License in

标的物：FDF

Subject: FDF

奥祺可以提供：

Aoqi provides:

中国市场的竞争机会评估
进口注册申报
市场推广和多渠道组合销售
China market opportunity assessment
Import registration filing
Promotion and multi-channel sales

成功案例

Track record

雌三醇凝胶美普他酚注射液奥司他韦胶囊Estriol gelMeptazinol injectionOseltamivir capsules

02 · LICENSE OUT

License out

标的物：FDF（奥祺研发）

Subject: FDF (developed by Aoqi)

产品特点：

Product profile:

近专利期重磅药物
完成 API 和制剂开发
部分产品已在半法规市场获批，或已在中国申报
Near-cliff blockbuster drugs
API and formulation development completed
Some approved in semi-regulated markets or filed in China

推荐产品

种子孵化服务

Incubation Services

S & E · IP · BD · FA · PM

孵化方向：

Focus areas:

基因疗法
细胞疗法
核酸药物
Gene therapy
Cell therapy
Nucleic acid therapeutics

服务内容

Services

S&EIPBDFAPMother supportS&EIPBDFAPMother support

INCUBATION NETWORK

孵化服务对象与合作网络

Incubation Network

筛选国内 CGT 方向早研项目进行孵化，为项目寻找国内外的研发及商业合作机会。

We scout early-stage CGT projects in China and connect them with R&D and commercial partners worldwide.

服务对象

Academic partners

北京大学复旦大学上海交通大学中科院上海药物所中国药科大学Peking UniversityFudan UniversityShanghai Jiao Tong UniversityShanghai Institute of Materia Medica, CASChina Pharmaceutical University

合作方

Partners

科研团队：中国境外的科研团队，跨领域跨国研究合作
制药企业：中国境内外的制药企业，项目许可 / 技术许可
VC 投资：资本参与
Research teams: overseas groups, cross-border and cross-disciplinary collaboration
Pharma companies: in and outside China, project and technology licensing
VC investment: capital participation

MARKET & SALES

市场与销售

Market & Sales

线上线下双线市场运营，深耕中国市场，精细化运营产品。

Online and offline dual-track market operations, deeply cultivated in China with refined product operations.

香港市场

Hong Kong market

跨境大湾区

Cross-border Greater Bay Area

国内市场

Domestic market

院内市场、OTC 市场、双通道药房

Hospital, OTC and dual-channel pharmacy

城市覆盖

City coverage

一线 / 二线城市，三线基层

Tier 1/2 cities and tier 3 grassroots

支付结构

Payment structure

医保市场，自费市场

Reimbursed and self-pay markets